ENZON PHARMACEUTICALS, INC. - FORM S-1/A - EX-23.2 - EXHIBIT 23.2 - September 15, 2020

Attached files

file filename
EX-99.8 - EXHIBIT 99.8 - ENZON PHARMACEUTICALS, INC.tm2029968d2_ex99-8.htm
EX-99.7 - EXHIBIT 99.7 - ENZON PHARMACEUTICALS, INC.tm2029968d2_ex99-7.htm
EX-99.6 - EXHIBIT 99.6 - ENZON PHARMACEUTICALS, INC.tm2029968d2_ex99-6.htm
EX-99.5 - EXHIBIT 99.5 - ENZON PHARMACEUTICALS, INC.tm2029968d2_ex99-5.htm
EX-99.4 - EXHIBIT 99.4 - ENZON PHARMACEUTICALS, INC.tm2029968d2_ex99-4.htm
EX-99.3 - EXHIBIT 99.3 - ENZON PHARMACEUTICALS, INC.tm2029968d2_ex99-3.htm
EX-99.2 - EXHIBIT 99.2 - ENZON PHARMACEUTICALS, INC.tm2029968d2_ex99-2.htm
EX-99.1 - EXHIBIT 99.1 - ENZON PHARMACEUTICALS, INC.tm2029968d2_ex99-1.htm
EX-8.1 - EXHIBIT 8.1 - ENZON PHARMACEUTICALS, INC.tm2029968d2_ex8-1.htm
EX-5.1 - EXHIBIT 5.1 - ENZON PHARMACEUTICALS, INC.tm2029968d2_ex5-1.htm
EX-4.3 - EXHIBIT 4.3 - ENZON PHARMACEUTICALS, INC.tm2029968d2_ex4-3.htm
EX-4.2 - EXHIBIT 4.2 - ENZON PHARMACEUTICALS, INC.tm2029968d2_ex4-2.htm
EX-3.5 - EXHIBIT 3.5 - ENZON PHARMACEUTICALS, INC.tm2029968d2_ex3-5.htm
S-1/A - S-1/A - ENZON PHARMACEUTICALS, INC.tm2029968d2_s1a.htm

 

Exhibit 23.2

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in this Amendment No. 1 to the Registration Statement of Enzon Pharmaceuticals, Inc. on Form S-1/A to be filed on or about September 14, 2020 of our report dated February 19, 2020, on our audits of the consolidated financial statements as of December 31, 2019 and 2018 and for each of the years then ended, which report was included in the Annual Report on Form 10-K filed February 19, 2020. We also consent to the reference to our firm under the caption “Experts” in this Registration Statement.

 

/s/ EisnerAmper LLP

 

EISNERAMPER LLP

Philadelphia, Pennsylvania

September 14, 2020

 

 

Stock widget

Investing forum

ENZON PHARMACEUTICALS, INC. Reports